Jefferies is out with its report today on Teleflex TFX, after former CEO Jeffrey Black unexpectedly resigned.
In a note to clients, Jefferies writes, "We believe that the unexpected departure indicates the change was more driven at the Board level as opposed to being led by Jeff Black himself. Given the move toward medical device pure-play, Jeff's replacement with Benson seems a telegraphed prescription given the former's expertise outside of med-tech experience and the latter's deep experience within the healthcare sector. "
Jefferies has a Buy rating and $63 price target on TFX.
Shares of TFX closed Monday at $57.32.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in